{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:46:02Z","timestamp":1793407562365,"version":"4.5.0"},"reference-count":181,"publisher":"Oxford University Press (OUP)","issue":"S1","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Cephalon, Inc., Frazer, PA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer-related fatigue (CRF) is one of the most prevalent symptoms patients with cancer experience, both during and after treatment. CRF is pervasive and affects patients' quality of life considerably. It is important, therefore, to understand the underlying pathophysiology of CRF in order to develop useful strategies for prevention and treatment. At present, the etiology of CRF is poorly understood and the relative contributions of the neoplastic disease, various forms of cancer therapy, and comorbid conditions (e.g., anemia, cachexia, sleep disorders, depression) remain unclear. In any individual, the etiology of CRF probably involves the dysregulation of several physiological and biochemical systems. Mechanisms proposed as underlying CRF include 5-HT neurotransmitter dysregulation, vagal afferent activation, alterations in muscle and ATP metabolism, hypothalamic\u2013pituitary\u2013adrenal axis dysfunction, circadian rhythm disruption, and cytokine dysregulation. Currently, these hypotheses are largely based on evidence from other conditions in which fatigue is a characteristic, in particular chronic fatigue syndrome and exercise-induced fatigue. The mechanisms that lead to fatigue in these conditions provide a theoretical basis for future research into the complex etiology of this distressing and debilitating symptom. An understanding of relevant mechanisms may offer potential routes for its prevention and treatment in patients with cancer.<\/jats:p>\n                  <jats:p>Disclosure of potential conflicts of interest is found at the end of this article.<\/jats:p>","DOI":"10.1634\/theoncologist.12-s1-22","type":"journal-article","created":{"date-parts":[[2007,6,16]],"date-time":"2007-06-16T06:58:18Z","timestamp":1181977098000},"page":"22-34","source":"Crossref","is-referenced-by-count":452,"title":["Mechanisms of Cancer-Related Fatigue"],"prefix":"10.1093","volume":"12","author":[{"given":"Julie L.","family":"Ryan","sequence":"first","affiliation":[{"name":"a Department of Dermatology, James P. Wilmot Cancer Center, Rochester, New York, USA"},{"name":"b Department of Radiation Oncology, James P. Wilmot Cancer Center, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Carroll","sequence":"additional","affiliation":[{"name":"b Department of Radiation Oncology, James P. Wilmot Cancer Center, Rochester, New York, USA"},{"name":"c Department of Family Medicine, James P. Wilmot Cancer Center, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth P.","family":"Ryan","sequence":"additional","affiliation":[{"name":"b Department of Radiation Oncology, James P. Wilmot Cancer Center, Rochester, New York, USA"},{"name":"d Department of Environmental Medicine, James P. Wilmot Cancer Center, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Mustian","sequence":"additional","affiliation":[{"name":"b Department of Radiation Oncology, James P. Wilmot Cancer Center, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Fiscella","sequence":"additional","affiliation":[{"name":"c Department of Family Medicine, James P. Wilmot Cancer Center, Rochester, New York, USA"},{"name":"e Department of Community and Preventive Medicine, James P. Wilmot Cancer Center, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Morrow","sequence":"additional","affiliation":[{"name":"b Department of Radiation Oncology, James P. Wilmot Cancer Center, Rochester, New York, USA"},{"name":"f f Department of Psychiatry, University of Rochester School of Medicine and Dentistry, James P. Wilmot Cancer Center, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,5,1]]},"reference":[{"key":"2021122208425755700_R1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF01845757","article-title":"A qualitative study to explore the concept of fatigue\/tiredness in cancer patients and in healthy individuals","volume":"4","author":"Glaus","year":"1996","journal-title":"Support Care Cancer"},{"key":"2021122208425755700_R2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1081\/CNV-200055960","article-title":"Management of cancer-related fatigue","volume":"23","author":"Morrow","year":"2005","journal-title":"Cancer Invest"},{"key":"2021122208425755700_R3","first-page":"151","article-title":"NCCN Practice Guidelines for Cancer-Related Fatigue","volume":"14","author":"Mock","year":"2000","journal-title":"Oncology (Williston Park)"},{"key":"2021122208425755700_R4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/ptj\/84.8.736","article-title":"Exercise as an intervention for cancer-related fatigue","volume":"84","author":"Watson","year":"2004","journal-title":"Phys Ther"},{"key":"2021122208425755700_R5","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1200\/JCO.2001.19.14.3385","article-title":"Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors","volume":"19","author":"Cella","year":"2001","journal-title":"J Clin Oncol"},{"key":"2021122208425755700_R6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(03)14186-4","article-title":"Assessment and management of cancer-related fatigue in adults","volume":"362","author":"Ahlberg","year":"2003","journal-title":"Lancet"},{"issue":"suppl 1","key":"2021122208425755700_R7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2008-1025803","article-title":"Application of principles of metabolic control to the problem of metabolic limitations in sprinting, middle-distance, and marathon running","volume":"7","author":"Newsholme","year":"1986","journal-title":"Int J Sports Med"},{"key":"2021122208425755700_R8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-1-22","article-title":"On the potential of glutamate transport in mental fatigue","volume":"1","author":"Ronnback","year":"2004","journal-title":"J Neuroinflammation"},{"key":"2021122208425755700_R9","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1152\/physrev.2001.81.4.1725","article-title":"Spinal and supraspinal factors in human muscle fatigue","volume":"81","author":"Gandevia","year":"2001","journal-title":"Physiol Rev"},{"key":"2021122208425755700_R10","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(04)15794-2","article-title":"Fatigue in neurological disorders","volume":"363","author":"Chaudhuri","year":"2004","journal-title":"Lancet"},{"key":"2021122208425755700_R11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-510X(00)00411-1","article-title":"Fatigue and basal ganglia","volume":"179","author":"Chaudhuri","year":"2000","journal-title":"J Neurol Sci"},{"key":"2021122208425755700_R12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2377-4-14","article-title":"Mechanisms underlying fatigue: A voxel-based morphometric study of chronic fatigue syndrome","volume":"4","author":"Okada","year":"2004","journal-title":"BMC Neurol"},{"key":"2021122208425755700_R13","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1152\/jappl.1992.72.5.1631","article-title":"Neurobiology of muscle fatigue","volume":"72","author":"Enoka","year":"1992","journal-title":"J Appl Physiol"},{"key":"2021122208425755700_R14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1152\/physrev.1978.58.4.763","article-title":"Kinesthetic sensibility","volume":"58","author":"McCloskey","year":"1978","journal-title":"Physiol Rev"},{"key":"2021122208425755700_R15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oso\/9780192630940.003.0003","volume-title":"Fatigue in Cancer","author":"Andrews","year":"2004"},{"key":"2021122208425755700_R16","first-page":"127","volume-title":"Advances in Myochemistry","author":"Newsholme","year":"1987"},{"key":"2021122208425755700_R17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00005768-199701000-00008","article-title":"Possible mechanisms of central nervous system fatigue during exercise","volume":"29","author":"Davis","year":"1997","journal-title":"Med Sci Sports Exerc"},{"issue":"suppl","key":"2021122208425755700_R18","doi-asserted-by":"crossref","first-page":"553S","DOI":"10.1093\/jn\/136.2.553S","article-title":"Exercise, serum free tryptophan, and central fatigue","volume":"136","author":"Fernstrom","year":"2006","journal-title":"J Nutr"},{"key":"2021122208425755700_R19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/0269881105053293","article-title":"Heterogeneity of serum tryptophan concentration and availability to the brain in patients with the chronic fatigue syndrome","volume":"19","author":"Badawy","year":"2005","journal-title":"J Psychopharmacol"},{"key":"2021122208425755700_R20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/978-1-4615-4709-9_90","article-title":"The role of tryptophan in fatigue in different conditions of stress","volume":"467","author":"Castell","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"2021122208425755700_R21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1748-1716.1989.tb08689.x","article-title":"Effect of sustained exercise on plasma amino acid concentrations and on 5-hydroxytryptamine metabolism in six different brain regions in the rat","volume":"136","author":"Blomstrand","year":"1989","journal-title":"Acta Physiol Scand"},{"issue":"suppl","key":"2021122208425755700_R22","doi-asserted-by":"crossref","first-page":"544S","DOI":"10.1093\/jn\/136.2.544S","article-title":"A role for branched-chain amino acids in reducing central fatigue","volume":"136","author":"Blomstrand","year":"2006","journal-title":"J Nutr"},{"key":"2021122208425755700_R23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-4899-1016-5_25","article-title":"Tryptophan, 5-hydroxytryptamine and a possible explanation for central fatigue","volume":"384","author":"Newsholme","year":"1995","journal-title":"Adv Exp Med Biol"},{"issue":"1 suppl","key":"2021122208425755700_R24","doi-asserted-by":"crossref","first-page":"274S","DOI":"10.1093\/jn\/136.1.274S","article-title":"Branched-chain amino acids and central fatigue","volume":"136","author":"Newsholme","year":"2006","journal-title":"J Nutr"},{"key":"2021122208425755700_R25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1476-5381.1985.tb09432.x","article-title":"Effects of conditioned running on plasma, liver and brain tryptophan and on brain 5-hydroxytrypta-mine metabolism of the rat","volume":"86","author":"Chaouloff","year":"1985","journal-title":"Br J Pharmacol"},{"key":"2021122208425755700_R26","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1152\/jappl.1993.74.6.3006","article-title":"Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue","volume":"74","author":"Bailey","year":"1993","journal-title":"J Appl Physiol"},{"key":"2021122208425755700_R27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1748-1716.1991.tb09225.x","article-title":"Effect of branched-chain amino acid supplementation on mental performance","volume":"143","author":"Blomstrand","year":"1991","journal-title":"Acta Physiol Scand"},{"key":"2021122208425755700_R28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00235174","article-title":"Administration of branched-chain amino acids during sustained exercise \u2013 effects on performance and on plasma concentration of some amino acids","volume":"63","author":"Blomstrand","year":"1991","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"2021122208425755700_R29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-201X.1997.547327000.x","article-title":"Influence of ingesting a solution of branched-chain amino acids on perceived exertion during exercise","volume":"159","author":"Blomstrand","year":"1997","journal-title":"Acta Physiol Scand"},{"key":"2021122208425755700_R30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00005768-199801000-00012","article-title":"Branched-chain amino acids prolong exercise during heat stress in men and women","volume":"30","author":"Mittleman","year":"1998","journal-title":"Med Sci Sports Exerc"},{"key":"2021122208425755700_R31","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1152\/japplphysiol.00357.2004","article-title":"Branched-chain amino acid supplementation and human performance when hypohydrated in the heat","volume":"97","author":"Cheuvront","year":"2004","journal-title":"J Appl Physiol"},{"key":"2021122208425755700_R32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1055\/s-2007-971136","article-title":"Effects of branched-chain amino acids and carbohydrate on fatigue during intermittent, high-intensity running","volume":"20","author":"Davis","year":"1999","journal-title":"Int J Sports Med"},{"key":"2021122208425755700_R33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-2007-978864","article-title":"Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans","volume":"30","author":"Struder","year":"1998","journal-title":"Horm Metab Res"},{"key":"2021122208425755700_R34","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1113\/jphysiol.1995.sp020854","article-title":"Ingestion of branched-chain amino acids and tryptophan during sustained exercise in man: Failure to affect performance","volume":"486","author":"van Hall","year":"1995","journal-title":"J Physiol"},{"key":"2021122208425755700_R35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00421-004-1206-2","article-title":"The effect of acute branched-chain amino acid supplementation on prolonged exercise capacity in a warm environment","volume":"93","author":"Watson","year":"2004","journal-title":"Eur J Appl Physiol"},{"key":"2021122208425755700_R36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1748-1716.1992.tb09338.x","article-title":"Effect of increased brain serotonergic activity on endurance performance in the rat","volume":"145","author":"Bailey","year":"1992","journal-title":"Acta Physiol Scand"},{"key":"2021122208425755700_R37","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1113\/expphysiol.1992.sp003660","article-title":"Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: Administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise","volume":"77","author":"Wilson","year":"1992","journal-title":"Exp Physiol"},{"key":"2021122208425755700_R38","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1249\/00005768-199305001-00440","article-title":"Effects of a serotonin (5-HT) agonist during prolonged exercise to fatigue in humans","volume":"25","author":"Davis","year":"1993","journal-title":"Med Sci Sports Exerc"},{"key":"2021122208425755700_R39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1113\/expphysiol.2004.027839","article-title":"Paroxetine administration failed [corrected] to influence human exercise capacity, perceived effort or hormone responses during prolonged exercise in a warm environment","volume":"89","author":"Strachan","year":"2004","journal-title":"Exp Physiol"},{"key":"2021122208425755700_R40","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1200\/JCO.2003.04.070","article-title":"Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program","volume":"21","author":"Morrow","year":"2003","journal-title":"J Clin Oncol"},{"key":"2021122208425755700_R41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-004-2175-1","article-title":"Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy","volume":"89","author":"Roscoe","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"2021122208425755700_R42","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/bmj.304.6833.1010","article-title":"Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome","volume":"304","author":"Bakheit","year":"1992","journal-title":"BMJ"},{"key":"2021122208425755700_R43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0165-0327(95)00026-J","article-title":"Contrasting neuroendocrine responses in depression and chronic fatigue syndrome","volume":"34","author":"Cleare","year":"1995","journal-title":"J Affect Disord"},{"key":"2021122208425755700_R44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/bmj.315.7101.164","article-title":"Increased brain serotonin function in men with chronic fatigue syndrome","volume":"315","author":"Sharpe","year":"1997","journal-title":"BMJ"},{"key":"2021122208425755700_R45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.biopsych.2004.10.031","article-title":"Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635","volume":"57","author":"Cleare","year":"2005","journal-title":"Biol Psychiatry"},{"key":"2021122208425755700_R46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0306-4530(97)00002-4","article-title":"Blunted serotonin-mediated activation of the hypothalamic\u2013pituitary\u2013adrenal axis in chronic fatigue syndrome","volume":"22","author":"Dinan","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"2021122208425755700_R47","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/er.2002-0014","article-title":"The neuroendocrinology of chronic fatigue syndrome","volume":"24","author":"Cleare","year":"2003","journal-title":"Endocr Rev"},{"key":"2021122208425755700_R48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000012065","article-title":"Effect of granisetron on performance status during high-dose interferon therapy","volume":"57","author":"Drapkin","year":"1999","journal-title":"Oncology"},{"key":"2021122208425755700_R49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(99)02936-0","article-title":"Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy","volume":"354","author":"Jones","year":"1999","journal-title":"Lancet"},{"key":"2021122208425755700_R50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/030097400446698","article-title":"Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists \u2013 preliminary results","volume":"113","author":"Spath","year":"2000","journal-title":"Scand J Rheumatol Suppl"},{"key":"2021122208425755700_R51","first-page":"285","article-title":"The effect of granisetron, a 5-HT3 receptor antagonist, in the treatment of chronic fatigue syndrome patients\u2014a pilot study","volume":"61","author":"The","year":"2003","journal-title":"Neth J Med"},{"key":"2021122208425755700_R52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s005200100293","article-title":"Fatigue associated with cancer and its treatment","volume":"10","author":"Morrow","year":"2002","journal-title":"Support Care Cancer"},{"key":"2021122208425755700_R53","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/BF01273312","article-title":"Effects of interferon-gamma, interleukin-1 beta, and tumor necrosis factor-alpha on the serotonin metabolism in the nucleus raphe dorsalis of the rat","volume":"104","author":"Clement","year":"1997","journal-title":"J Neural Transm"},{"key":"2021122208425755700_R54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0197-0186(98)00026-6","article-title":"Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6","volume":"33","author":"Mossner","year":"1998","journal-title":"Neurochem Int"},{"key":"2021122208425755700_R55","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/sj.npp.1301029","article-title":"The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters","volume":"31","author":"Zhu","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"2021122208425755700_R56","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(00)02088-9","article-title":"Cytokine-induced sickness behaviour: Mechanisms and implications","volume":"25","author":"Konsman","year":"2002","journal-title":"Trends Neurosci"},{"key":"2021122208425755700_R57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/S1461145702003103","article-title":"The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans","volume":"5","author":"Wichers","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"2021122208425755700_R58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/frne.1994.1013","article-title":"Regulation of pituitary ACTH secretion during chronic stress","volume":"15","author":"Aguilera","year":"1994","journal-title":"Front Neuroendocrinol"},{"key":"2021122208425755700_R59","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1523\/JNEUROSCI.06-10-02908.1986","article-title":"Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress","volume":"6","author":"Chappell","year":"1986","journal-title":"J Neurosci"},{"key":"2021122208425755700_R60","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1523\/JNEUROSCI.11-03-00585.1991","article-title":"Differential regulation of corticotrophin-releasing factor mRNA in rat brain regions by glucocorticoids and stress","volume":"11","author":"Imaki","year":"1991","journal-title":"J Neurosci"},{"key":"2021122208425755700_R61","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1749-6632.1998.tb09599.x","article-title":"Inflammatory disease as chronic stress","volume":"840","author":"Shanks","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"2021122208425755700_R62","first-page":"1394","article-title":"Paradoxical responses of hypothalamic corticotropin-releasing factor messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress","volume":"130","author":"Harbuz","year":"1992","journal-title":"Endocrinology"},{"key":"2021122208425755700_R63","first-page":"1560","article-title":"Defective corticotropin-releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: Implications for cholestatic liver disease-related sickness behaviors","volume":"22","author":"Swain","year":"1995","journal-title":"Hepatology"},{"key":"2021122208425755700_R64","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1172\/JCI116408","article-title":"Suppression of hypothalamic\u2013 pituitary\u2013adrenal axis responsiveness to stress in a rat model of acute cholestasis","volume":"91","author":"Swain","year":"1993","journal-title":"J Clin Invest"},{"key":"2021122208425755700_R65","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.psyneuen.2006.04.003","article-title":"Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: Dopaminergic, noradrenergic and thyroid correlates","volume":"31","author":"Duval","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"2021122208425755700_R66","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1600-0447.1998.tb10092.x","article-title":"Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia","volume":"98","author":"Maes","year":"1998","journal-title":"Acta Psychiatr Scand"},{"key":"2021122208425755700_R67","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1210\/jcem.86.8.7735","article-title":"Hypothalamo\u2013pituitary\u2013adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy","volume":"86","author":"Cleare","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208425755700_R68","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1210\/jcem-73-6-1224","article-title":"Evidence for impaired activation of the hypothalamic\u2013pituitary\u2013adrenal axis in patients with chronic fatigue syndrome","volume":"73","author":"Demitrack","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208425755700_R69","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-0447.1998.tb10030.x","article-title":"Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome","volume":"97","author":"Scott","year":"1998","journal-title":"Acta Psychiatr Scand"},{"key":"2021122208425755700_R70","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00006842-200207000-00010","article-title":"Fatigue and proinflammatory cytokine activity in breast cancer survivors","volume":"64","author":"Bower","year":"2002","journal-title":"Psychosom Med"},{"key":"2021122208425755700_R71","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.psy.0000155666.55034.c6","article-title":"Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue","volume":"67","author":"Bower","year":"2005","journal-title":"Psychosom Med"},{"key":"2021122208425755700_R72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000119004","article-title":"The \u2018Trier Social Stress Test\u2019\u2014a tool for investigating psychobiological stress responses in a laboratory setting","volume":"28","author":"Kirschbaum","year":"1993","journal-title":"Neuropsychobiology"},{"key":"2021122208425755700_R73","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.psyneuen.2004.06.003","article-title":"Diurnal cortisol rhythm and fatigue in breast cancer survivors","volume":"30","author":"Bower","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"2021122208425755700_R74","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1191\/0269216303pm780oa","article-title":"Symptoms in advanced cancer: Relationship to endogenous cortisol levels","volume":"17","author":"Lundstr\u00f6m","year":"2003","journal-title":"Palliat Med"},{"key":"2021122208425755700_R75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0173(93)90005-K","article-title":"Physiopharmacological interactions between stress hormones and central serotonergic systems","volume":"18","author":"Chaouloff","year":"1993","journal-title":"Brain Res Brain Res Rev"},{"key":"2021122208425755700_R76","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/gyno.1995.1274","article-title":"Adrenal function following high-dose steroids in ovarian cancer patients","volume":"59","author":"Del Priore","year":"1995","journal-title":"Gynecol Oncol"},{"key":"2021122208425755700_R77","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/1469-8986.3940491","article-title":"Reduction in serum cortisol after platinum based chemotherapy for cancer: A role for the HPA axis in treatment-related nausea?","volume":"39","author":"Morrow","year":"2002","journal-title":"Psychophysiology"},{"key":"2021122208425755700_R78","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2002-021994","article-title":"Assessment of the hypothalamo\u2013pituitary\u2013adrenal axis in patients treated with radio-therapy and chemotherapy for childhood brain tumor","volume":"88","author":"Schmiegelow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208425755700_R79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-0173(96)00012-4","article-title":"The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine and immune interactions","volume":"23","author":"McEwen","year":"1997","journal-title":"Brain Res Brain Res Rev"},{"key":"2021122208425755700_R80","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/cyto.1997.0289","article-title":"Diurnal rhythms of pro-inflammatory cytokines: Regulation by plasma cortisol and therapeutic implications","volume":"10","author":"Petrovsky","year":"1998","journal-title":"Cytokine"},{"key":"2021122208425755700_R81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0889-8529(01)00005-6","article-title":"Sleep, the hypothalamic\u2013pituitary\u2013adrenal axis, and cytokines: Multiple interactions and disturbances in sleep disorders","volume":"31","author":"Vgontzas","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2021122208425755700_R82","first-page":"1137","article-title":"Cancer-associated alteration of circadian rhythms in carcinoembryonic antigen (CEA) and alpha-feto-protein (AFP) in humans","volume":"6","author":"Focan","year":"1986","journal-title":"Anticancer Res"},{"key":"2021122208425755700_R83","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/sj.bjc.6602859","article-title":"Circadian function in patients with advanced non-small-cell lung cancer","volume":"93","author":"Levin","year":"2005","journal-title":"Br J Cancer"},{"key":"2021122208425755700_R84","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1097-0215(19970117)70:2<241::AID-IJC16>3.0.CO;2-L","article-title":"Circadian-system alterations during cancer processes: A review","volume":"70","author":"Mormont","year":"1997","journal-title":"Int J Cancer"},{"key":"2021122208425755700_R85","first-page":"165","article-title":"[Study of circadian rhythms of activity by actometry: Preliminary results in 30 patients with metastatic colorectal cancer.]","volume":"44","author":"Mormont","year":"1996","journal-title":"Pathol Biol (Paris)"},{"key":"2021122208425755700_R86","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0889-1591(03)00078-3","article-title":"Circadian disruption in cancer: A neuroendocrine-immune pathway from stress to disease?","volume":"17","author":"Sephton","year":"2003","journal-title":"Brain Behav Immun"},{"key":"2021122208425755700_R87","first-page":"69","article-title":"Studies on circadian periodicity of urinary corticoids in carcinoma of the breast","volume":"12","author":"Singh","year":"1998","journal-title":"In Vivo"},{"key":"2021122208425755700_R88","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF01198101","article-title":"Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors","volume":"121","author":"Touitou","year":"1995","journal-title":"J Cancer Res Clin Oncol"},{"key":"2021122208425755700_R89","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/bjc.1996.524","article-title":"Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: Relationships with tumour marker antigens","volume":"74","author":"Touitou","year":"1996","journal-title":"Br J Cancer"},{"issue":"suppl 1","key":"2021122208425755700_R90","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1634\/theoncologist.12-S1-35","article-title":"Cancer-related fatigue and sleep disorders","volume":"12","author":"Roscoe","year":"2007","journal-title":"The Oncologist"},{"key":"2021122208425755700_R91","first-page":"51","article-title":"Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy","volume":"25","author":"Berger","year":"1998","journal-title":"Oncol Nurs Forum"},{"key":"2021122208425755700_R92","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/(SICI)1097-0215(19981109)78:4<421::AID-IJC5>3.0.CO;2-W","article-title":"Non-invasive estimation of the circadian rhythm in serum cortisol in patients with ovarian or colorectal cancer","volume":"78","author":"Mormont","year":"1998","journal-title":"Int J Cancer"},{"key":"2021122208425755700_R93","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1081\/CBI-120002606","article-title":"Contribution of the rest\u2013activity circadian rhythm to quality of life in cancer patients","volume":"19","author":"Mormont","year":"2002","journal-title":"Chronobiol Int"},{"key":"2021122208425755700_R94","first-page":"3038","article-title":"Marked 24-h rest\/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status","volume":"6","author":"Mormont","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2021122208425755700_R95","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/1078-0432.CCR-04-2000","article-title":"Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest\u2013activity patterns in patients with metastatic colorectal cancer","volume":"11","author":"Rich","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2021122208425755700_R96","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00520-001-0317-0","article-title":"Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment","volume":"10","author":"Roscoe","year":"2002","journal-title":"Support Care Cancer"},{"key":"2021122208425755700_R97","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00006842-199701000-00006","article-title":"Circadian immune measures in healthy volunteers: Relationship to hypothalamic\u2013pituitary\u2013adrenal axis hormones and sympathetic neurotransmitters","volume":"59","author":"Kronfol","year":"1997","journal-title":"Psychosom Med"},{"key":"2021122208425755700_R98","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jnci\/92.12.994","article-title":"Diurnal cortisol rhythm as a predictor of breast cancer survival","volume":"92","author":"Sephton","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2021122208425755700_R99","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cncr.20777","article-title":"The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer","volume":"103","author":"Brown","year":"2005","journal-title":"Cancer"},{"key":"2021122208425755700_R100","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0003-9993(03)00437-4","article-title":"Differences in physical performance between men and women with and without lymphoma","volume":"84","author":"Lee","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"key":"2021122208425755700_R101","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/(SICI)1097-4598(199605)19:5<621::AID-MUS10>3.0.CO;2-Q","article-title":"Reduced oxidative muscle metabolism in chronic fatigue syndrome","volume":"19","author":"McCully","year":"1996","journal-title":"Muscle Nerve"},{"key":"2021122208425755700_R102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1081-1206(10)62595-1","article-title":"Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome","volume":"82","author":"Forsyth","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2021122208425755700_R103","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0960-8966(98)00021-2","article-title":"Heterogeneity in chronic fatigue syndrome: Evidence from magnetic resonance spectroscopy of muscle","volume":"8","author":"Lane","year":"1998","journal-title":"Neuromuscul Disord"},{"key":"2021122208425755700_R104","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/00365599709070349","article-title":"Altered muscle energy metabolism in post-absorptive patients with chronic renal failure","volume":"31","author":"Pastoris","year":"1997","journal-title":"Scand J Urol Nephrol"},{"key":"2021122208425755700_R105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.bjc.6600074","article-title":"Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans","volume":"86","author":"Collins","year":"2002","journal-title":"Br J Cancer"},{"key":"2021122208425755700_R106","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/003655202753387446","article-title":"Obstructive jaundice results in increased liver expression of uncoupling protein 2 and intact skeletal muscle glucose metabolism in the rat","volume":"37","author":"Isaksson","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"2021122208425755700_R107","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/jcb.10601","article-title":"Skeletal muscle metabolism in physiology and in cancer disease","volume":"90","author":"Giordano","year":"2003","journal-title":"J Cell Biochem"},{"key":"2021122208425755700_R108","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jnci\/92.4.321","article-title":"Randomized clinical trial of adenosine 5\u2032-triphosphate in patients with advanced non-small-cell lung cancer","volume":"92","author":"Agteresch","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2021122208425755700_R109","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1113\/jphysiol.1937.sp003516","article-title":"The anti-strychnine action of acetylcholine, prostigmine and related substances, and of central vagus stimulation","volume":"90","author":"Schweitzer","year":"1937","journal-title":"J Physiol"},{"key":"2021122208425755700_R110","first-page":"1","article-title":"Afferent vagal C fibre innervation of the lungs and airways and its functional significance","volume":"99","author":"Coleridge","year":"1984","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"2021122208425755700_R111","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1249\/00005768-199404000-00010","article-title":"Vagal afferents reflexly inhibit exercise in conscious rats","volume":"26","author":"DiCarlo","year":"1994","journal-title":"Med Sci Sports Exerc"},{"key":"2021122208425755700_R112","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00595817","article-title":"Effects of certain cerebral lesions on the J reflex","volume":"343","author":"Kalia","year":"1973","journal-title":"Pflugers Arch"},{"key":"2021122208425755700_R113","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0024-3205(83)90659-8","article-title":"Caerulein, a cholecystokinin-related peptide, depresses somatic function via the vagal afferent system","volume":"33","author":"Kawasaki","year":"1983","journal-title":"Life Sci"},{"key":"2021122208425755700_R114","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1152\/physrev.1973.53.1.159","article-title":"Vagal sensory receptors and their reflex effects","volume":"53","author":"Paintal","year":"1973","journal-title":"Physiol Rev"},{"key":"2021122208425755700_R115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1152\/jappl.1993.74.1.103","article-title":"Stimulation of vagal afferents inhibits locomotion in mesencephalic cats","volume":"74","author":"Pickar","year":"1993","journal-title":"J Appl Physiol"},{"key":"2021122208425755700_R116","first-page":"R706","article-title":"The thromoboxane A2 mimetic U-46619 inhibits somatomotor activity via a vagal reflex from the lung","volume":"275","author":"Pickar","year":"1998","journal-title":"Am J Physiol"},{"key":"2021122208425755700_R117","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-1838(93)90360-7","article-title":"Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret","volume":"45","author":"Blackshaw","year":"1993","journal-title":"J Auton Nerv Syst"},{"key":"2021122208425755700_R118","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0165-1838(93)90361-W","article-title":"Effects of 5-hydroxytryptamine (5-HT) on the discharge of vagal mechanoreceptors and motility in the upper gastrointestinal tract of the ferret","volume":"45","author":"Blackshaw","year":"1993","journal-title":"J Auton Nerv Syst"},{"key":"2021122208425755700_R119","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1523\/JNEUROSCI.18-22-09471.1998","article-title":"Activation of vagal afferents after intravenous injection of interleukin-1\u03b2: Role of endogenous prostaglandins","volume":"18","author":"Ek","year":"1998","journal-title":"J Neurosci"},{"key":"2021122208425755700_R120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-1838(96)00098-7","article-title":"The afferent discharges from sensors for interleukin-1b in the hepatoportal system in the anaesthetized rat","volume":"61","author":"Niijima","year":"1996","journal-title":"J Auton Nerv Syst"},{"key":"2021122208425755700_R121","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1164\/ajrccm\/136.1.184","article-title":"Extreme dyspnea from unilateral pulmonary venous obstruction. Demonstration of a vagal mechanism and relief by right vagotomy","volume":"136","author":"Davies","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"2021122208425755700_R122","first-page":"238","article-title":"Sensations from J receptors","volume":"10","author":"Paintal","year":"1995","journal-title":"News Physiol Sci"},{"key":"2021122208425755700_R123","first-page":"R1246","article-title":"Subdiaphragmatic vagotomy blocks the sleep-and fever-promoting effects of interleukin-1\u03b2","volume":"273","author":"Hansen","year":"1997","journal-title":"Am J Physiol"},{"key":"2021122208425755700_R124","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.0507191102","article-title":"Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness","volume":"102","author":"Johnson","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021122208425755700_R125","first-page":"R406","article-title":"Vagotomy attenuates but does not prevent the somnogenic and febrile effects of lipopolysaccharide in rats","volume":"274","author":"Kapas","year":"1998","journal-title":"Am J Physiol"},{"key":"2021122208425755700_R126","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0024-3205(98)00010-1","article-title":"Somnogenic and pyrogenic effects of interleukin-1b and lipopolysaccharide in intact and vagotomized rats","volume":"62","author":"Opp","year":"1998","journal-title":"Life Sci"},{"key":"2021122208425755700_R127","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1523\/JNEUROSCI.18-06-02247.1998","article-title":"Vagotomy blocks the induction of interleukin-1\u03b2 (IL-1\u03b2) mRNA in the brain of rats in response to systemic IL-1\u03b2","volume":"18","author":"Hansen","year":"1998","journal-title":"J Neurosci"},{"key":"2021122208425755700_R128","first-page":"81","article-title":"Correlates of fatigue in people with breast or lung cancer","volume":"18","author":"Blesch","year":"1991","journal-title":"Oncol Nurs Forum"},{"key":"2021122208425755700_R129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0091-6749(98)70090-9","article-title":"Chronic fatigue syndrome: Identification of distinct subgroups on the basis of allergy and psychologic variables","volume":"102","author":"Borish","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"2021122208425755700_R130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-108-3-387","article-title":"Chronic fatigue syndrome: A working case definition","volume":"108","author":"Holmes","year":"1988","journal-title":"Ann Intern Med"},{"key":"2021122208425755700_R131","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0749-2081(88)90069-1","article-title":"Tumor necrosis factor: Current clinical status and implications for nursing management","volume":"4","author":"Moldawer","year":"1988","journal-title":"Semin Oncol Nurs"},{"key":"2021122208425755700_R132","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-349-13397-0_25","volume-title":"Key Aspects of Comfort: Management of Pain, Fatigue, and Nausea","author":"Piper","year":"1989"},{"key":"2021122208425755700_R133","first-page":"23","article-title":"Fatigue and the cancer experience: The state of the knowledge","volume":"21","author":"Winningham","year":"1994","journal-title":"Oncol Nurs Forum"},{"key":"2021122208425755700_R134","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/11354","article-title":"Upregulation of RGS7 may contribute to tumor necrosis factor-induced changes in central nervous function","volume":"5","author":"Benzing","year":"1999","journal-title":"Nat Med"},{"key":"2021122208425755700_R135","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"2021122208425755700_R136","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","article-title":"Neuropsychiatric adverse effects of interferon-a: Recognition and management","volume":"19","author":"Raison","year":"2005","journal-title":"CNS Drugs"},{"key":"2021122208425755700_R137","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood.V78.5.1205.1205","article-title":"Phase I\u2013II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation","volume":"78","author":"Bianco","year":"1991","journal-title":"Blood"},{"key":"2021122208425755700_R138","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0885-3924(93)90127-H","article-title":"Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer","volume":"8","author":"Greenberg","year":"1993","journal-title":"J Pain Symptom Manage"},{"key":"2021122208425755700_R139","first-page":"71","volume-title":"Important Advances in Oncology","author":"Hallahan","year":"1993"},{"key":"2021122208425755700_R140","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0360-3016(95)00279-8","article-title":"Induction of acute phase gene expression by brain irradiation","volume":"33","author":"Hong","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208425755700_R141","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cyto.2003.10.004","article-title":"Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy","volume":"25","author":"Pusztai","year":"2004","journal-title":"Cytokine"},{"key":"2021122208425755700_R142","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/infdis\/162.6.1412-a","article-title":"Serum neopterin and interleukin-6 levels in chronic fatigue syndrome","volume":"162","author":"Chao","year":"1990","journal-title":"J Infect Dis"},{"issue":"suppl 1","key":"2021122208425755700_R143","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1093\/clinids\/18.Supplement_1.S147","article-title":"Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: Interrelations with cellular sources and patterns of soluble immune mediator expression","volume":"18","author":"Patarca","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2021122208425755700_R144","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","article-title":"Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease","volume":"106","author":"Nishimoto","year":"2005","journal-title":"Blood"},{"key":"2021122208425755700_R145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00296-004-0463-z","article-title":"The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis\u2014a pilot study","volume":"25","author":"Omdal","year":"2005","journal-title":"Rheumatol Int"},{"key":"2021122208425755700_R146","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.10697","article-title":"Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial","volume":"48","author":"Weinblatt","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2021122208425755700_R147","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/jnci\/91.19.1616","article-title":"Chemotherapy-induced anemia in adults: Incidence and treatment","volume":"91","author":"Groopman","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2021122208425755700_R148","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1634\/theoncologist.7-2-126","article-title":"Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum-and nonplatinum-based chemotherapy: A retrospective subanalysis of two large, community-based trials","volume":"7","author":"Glaspy","year":"2002","journal-title":"The Oncologist"},{"issue":"suppl 1","key":"2021122208425755700_R149","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1634\/theoncologist.8-suppl_1-19","article-title":"Anemia in cancer: Some pathophysiological aspects","volume":"8","author":"Dicato","year":"2003","journal-title":"The Oncologist"},{"key":"2021122208425755700_R150","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.V79.8.1987.1987","article-title":"Effect of inflammatory cytokines on hypoxia-induced erythropoietin production","volume":"79","author":"Faquin","year":"1992","journal-title":"Blood"},{"key":"2021122208425755700_R151","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000419481","article-title":"Modulation of the production of erythropoietin by cytokines: In vitro studies and their clinical implications","volume":"87","author":"Jelkmann","year":"1990","journal-title":"Contrib Nephrol"},{"issue":"suppl 2","key":"2021122208425755700_R152","first-page":"13","article-title":"The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue","volume":"34","author":"Cella","year":"1997","journal-title":"Semin Hematol"},{"key":"2021122208425755700_R153","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.1998.16.10.3412","article-title":"Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study. Procrit Study Group","volume":"16","author":"Demetri","year":"1998","journal-title":"J Clin Oncol"},{"key":"2021122208425755700_R154","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2001.19.11.2865","article-title":"Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial","volume":"19","author":"Littlewood","year":"2001","journal-title":"J Clin Oncol"},{"key":"2021122208425755700_R155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","article-title":"Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system","volume":"13","author":"Yellen","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"2021122208425755700_R156","first-page":"45","volume-title":"Fatigue and Cancer. European School of Oncology Scientific Updates, 5","author":"Bron","year":"2001"},{"key":"2021122208425755700_R157","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0140-6736(91)91371-Z","article-title":"Red blood cell magnesium and chronic fatigue syndrome","volume":"337","author":"Cox","year":"1991","journal-title":"Lancet"},{"key":"2021122208425755700_R158","first-page":"185","volume-title":"Fatigue and Cancer. European School of Oncology Scientific Updates, 5","author":"Mercuriali","year":"2001"},{"key":"2021122208425755700_R159","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"DeWys","year":"1980","journal-title":"Am J Med"},{"issue":"suppl 1S","key":"2021122208425755700_R160","doi-asserted-by":"crossref","first-page":"243S","DOI":"10.1093\/jn\/129.1.243S","article-title":"Wasting in cancer","volume":"129","author":"Tisdale","year":"1999","journal-title":"J Nutr"},{"key":"2021122208425755700_R161","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/0-387-26283-0_9","article-title":"Cytokines as mediators and targets for cancer cachexia","volume":"130","author":"Argiles","year":"2006","journal-title":"Cancer Treat Res"},{"key":"2021122208425755700_R162","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/jnci\/89.23.1763","article-title":"Biology of cachexia","volume":"89","author":"Tisdale","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"2021122208425755700_R163","first-page":"340","article-title":"Molecular pathways leading to cancer cachexia","volume":"20","author":"Tisdale","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"2021122208425755700_R164","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpsychires.2005.12.005","article-title":"An investigation of hypothalamic\u2013pituitary\u2013adrenal axis hyperactivity in anorexia nervosa: The role of CRH and AVP","volume":"41","author":"Connan","year":"2007","journal-title":"J Psychiatr Res"},{"key":"2021122208425755700_R165","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1200\/JCO.2000.18.4.743","article-title":"Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life","volume":"18","author":"Bower","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122208425755700_R166","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0885-3924(99)00082-2","article-title":"Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates","volume":"18","author":"Jacobsen","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"2021122208425755700_R167","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/107327489900600304","article-title":"Is fatigue a long-term side effect of breast cancer treatment?","volume":"6","author":"Jacobsen","year":"1999","journal-title":"Cancer Control"},{"key":"2021122208425755700_R168","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/978-1-349-13397-0_28","volume-title":"Key Aspects of Comfort: Management of Pain, Fatigue and Nausea","author":"Jamar","year":"1989"},{"key":"2021122208425755700_R169","first-page":"383","article-title":"Chemotherapy-induced fatigue and patient-reported psychological depression","volume":"11","author":"Morrow","year":"1992","journal-title":"Proc Am Soc Clin Oncol"},{"key":"2021122208425755700_R170","first-page":"229","article-title":"Distinguishing fatigue and depression in patients with cancer","volume":"8","author":"Jacobsen","year":"2003","journal-title":"Semin Clin Neuropsychiatry"},{"key":"2021122208425755700_R171","first-page":"1","author":"Wessely","year":"1999"},{"key":"2021122208425755700_R172","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s005200050142","article-title":"Fatigue, depression and quality of life in cancer patients: How are they related?","volume":"6","author":"Visser","year":"1998","journal-title":"Support Care Cancer"},{"key":"2021122208425755700_R173","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000124489","article-title":"Effects of corticotrophin-releasing factor and growth hormone-releasing factor on sleep and activity in rats","volume":"42","author":"Ehlers","year":"1986","journal-title":"Neuroendocrinology"},{"key":"2021122208425755700_R174","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000124986","article-title":"Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man","volume":"48","author":"Holsboer","year":"1988","journal-title":"Neuroendocrinology"},{"key":"2021122208425755700_R175","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/sj.npp.1300362","article-title":"Acute cortical administration promotes sleep intensity in man","volume":"29","author":"Friess","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"2021122208425755700_R176","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0149-7634(01)00024-0","article-title":"Corticotropin-releasing hormone (CRH) as a regulator of waking","volume":"25","author":"Chang","year":"2001","journal-title":"Neurosci Biobehav Rev"},{"key":"2021122208425755700_R177","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1188\/02.ONF.1334-1340","article-title":"The trajectory of fatigue in adult patients with breast and ovarian cancer receiving chemotherapy","volume":"29","author":"Payne","year":"2002","journal-title":"Oncol Nurs Forum"},{"key":"2021122208425755700_R178","article-title":"Biomarkers, sleep and fatigue characteristics in women with breast cancer","volume-title":"Proceedings of the Seventh National Conference on Cancer Nursing Research","author":"Payne","year":"2003"},{"key":"2021122208425755700_R179","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/0033-295X.105.1.83","article-title":"Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition","volume":"105","author":"Maier","year":"1998","journal-title":"Psychol Rev"},{"key":"2021122208425755700_R180","article-title":"Evidence of corticotrophin-releasing hormone (CRH) deficiency in patients with idiopathic hypersomnia: Clinical and pathophysiological implications","volume-title":"Presented at the 79th Endocrine Society Meeting","author":"Vgontzas","year":"1997"},{"key":"2021122208425755700_R181","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0753-3322(01)00140-8","article-title":"Cytokine deregulation in cancer","volume":"55","author":"Kurzrock","year":"2001","journal-title":"Biomed Pharmacother"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.12-S1-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.12-S1-22","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/12\/S1\/22\/41835900\/oncolo_12_s1_22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/12\/S1\/22\/41835900\/oncolo_12_s1_22.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T22:00:06Z","timestamp":1707948006000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/12\/S1\/22\/6395771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":181,"journal-issue":{"issue":"S1","published-online":{"date-parts":[[2007,5,1]]},"published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.12-s1-22","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,5,1]]},"published":{"date-parts":[[2007,5,1]]}}}